DHR

Danaher Corporation | Cotação de Ações

Última atualização31/01/2025, 18:00:02

PreçoUS$ 222,74

Variação (dia)-US$ 0,34 (-0.15%)▼

Min. 52 SemanasUS$ 221,34

Máx. 52 SemanasUS$ 281,70

Capitalização de mercado--

Endereço: 2200 Pennsylvania Avenue, North West, Washington, DC, 20037-1701

Telefone: 202 828 0850

Funcionários: 61.000

Danaher CorporationDHR

US$ 222,74

- 0,340,15%

31/01/2025 18:00:02

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualUS$ 222,74

Valor de mercado--

AberturaUS$ 248,89

Preço máximoUS$ 227,50

Preço mínimoUS$ 222,37

VolumeUS$ 4,8 mi

Fechamento anteriorUS$ 223,08

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Ações relacionadas

Thermo Fisher Scientific Inc.

TMO ▼1.11% | US$ 526,07

Stryker Corporation

SYK ▼2.31% | US$ 367,11

Becton, Dickinson and Company

BDX ▲0.37% | US$ 228,49

Zoetis Inc.

ZTS ▼0.92% | US$ 164,60

Linde plc

LIN ▼1.34% | US$ 422,98

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.

Busque ativos específicos e obtenha informações detalhadas sobre suas cotações

Utilize a função de busca para encontrar informações detalhadas sobre ativos específicos. Oferecemos dados precisos e atualizados, permitindo que você tome decisões informadas com base nas informações mais recentes do mercado.

Encontre respostas para suas dúvidas sobre investimentos em nossa seção de Perguntas Frequentes (FAQ)

Acesse a seção de Perguntas Frequentes da brapi para esclarecer dúvidas sobre investimentos. Nossa FAQ fornece informações concisas, abordando tópicos relevantes para investidores, contribuindo para uma compreensão mais clara do mercado financeiro.